Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9.65M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
21.9M
-
Shares change
-
-1.91M
-
Total reported value, excl. options
-
$64.6M
-
Value change
-
-$5.41M
-
Put/Call ratio
-
0.12
-
Number of buys
-
30
-
Number of sells
-
-52
-
Price
-
$2.95
Significant Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q2 2023
99 filings reported holding ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value as of Q2 2023.
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.9M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (4.8M shares), BAKER BROS. ADVISORS LP (3.15M shares), BML Capital Management, LLC (1.86M shares), VANGUARD GROUP INC (1.7M shares), Simplify Asset Management Inc. (1.49M shares), Point72 Asset Management, L.P. (905K shares), MILLENNIUM MANAGEMENT LLC (804K shares), BlackRock Inc. (670K shares), BANK OF AMERICA CORP /DE/ (470K shares), and RENAISSANCE TECHNOLOGIES LLC (439K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.